Atorvastatin Calcium
Product Images NDC 68071-2687

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2687). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2687 9)

Atorvastatin Calcium 20 mg tablets label from NuCare Pharmaceuticals, Inc., containing 90 tablets. The label includes NDC 68071-2687-9 and manufacturing information by Sun Pharmaceutical Industries, Mumbai, India. It features dosage instructions, product number R1520090, and standard warnings about keeping out of reach of children and storage temperature (68-77°F).*

FDA Label Image

Structure (Image 01)

Chemical structure of Atorvastatin Calcium, showing its molecular arrangement including aromatic rings, hydroxyl groups, and calcium ions associated with the molecule.*

FDA Label Image

Figure1 (Image 02)

A line chart comparing cumulative incidence (%) over time (years) between Atorvastatin and placebo groups. The chart shows lower incidence for Atorvastatin compared to placebo, with a hazard ratio (HR) of 0.64 and a p-value of 0.0005, plotted over approximately 3.5 years.*

FDA Label Image

Figure 2 (Image 03)

A line graph comparing the cumulative hazard (%) over time (up to 4 years) between Placebo and Atorvastatin. The x-axis shows time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. Placebo shows a higher cumulative hazard than Atorvastatin, with a hazard ratio (HR) of 0.63 (0.48-0.83) and p=0.001 indicating statistical significance.*

FDA Label Image

Figure 3 (Image 04)

A line graph showing the percentage of subjects experiencing a major cardiovascular event over time in years, comparing two doses of Atorvastatin (10 mg and 80 mg). The graph indicates a lower event rate for the 80 mg dose with a hazard ratio (HR) of 0.78 and a p-value of 0.0002, demonstrating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.